Yoon-Pin Lim
Overview
Explore the profile of Yoon-Pin Lim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
317
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sadeghi S, Masurkar N, Vallerinteavide Mavelli G, Deshpande S, Kok Yong Tan W, Yee S, et al.
ACS Nano
. 2022 Jun;
16(7):10292-10301.
PMID: 35653306
Bioorthogonal catalysis (BC) generates chemical reactions not present in normal physiology for the purpose of disease treatment. Because BC catalytically produces the desired therapy only at the site of disease,...
2.
Lan W, Hou A, Lakshminarayanan R, Lim Y, Tong L
FEBS Lett
. 2018 Mar;
592(7):1173-1184.
PMID: 29513395
Long intergenic noncoding RNAs (lincRNAs) are not fully characterized in disease, although many are involved in controlling differentiation. We discovered and sequenced a novel 4.4 kb human lincRNA called linc-9432...
3.
Toh C, Chan J, Chong Z, Wang H, Guo H, Satapathy S, et al.
Cell Rep
. 2016 Jun;
15(12):2597-607.
PMID: 27292646
Incomplete knowledge of the mechanisms at work continues to hamper efforts to maximize reprogramming efficiency. Here, we present a systematic genome-wide RNAi screen to determine the global regulators during the...
4.
Tan H, Toh C, Ma D, Yang B, Liu T, Lu J, et al.
Stem Cells Transl Med
. 2014 Mar;
3(5):586-98.
PMID: 24646489
Induced pluripotent stem cells (iPSCs) derived from somatic cells of patients can be a good model for studying human diseases and for future therapeutic regenerative medicine. Current initiatives to establish...
5.
Choong L, Lim S, Chen Y, Loh M, Toy W, Wong C, et al.
Genes Chromosomes Cancer
. 2011 Jul;
50(10):837-47.
PMID: 21769958
Understanding the molecular etiology of cancer and increasing the number of drugs and their targets are critical to cancer management. In our attempt to unravel novel breast-cancer associated proteins, we...
6.
Yang Y, Yixuan Y, Lim S, Kiat L, Choong L, Yee C, et al.
J Proteome Res
. 2010 Sep;
9(9):4767-78.
PMID: 20812763
Cancer progression is governed by multifaceted interactions of cancer cells with their microenvironment and one of these ways is through secreted compounds. Substances released by gastric cancer cells have not...
7.
Chong P, Lee H, Zhou J, Liu S, Loh M, So J, et al.
J Proteomics
. 2010 Apr;
73(8):1632-40.
PMID: 20399916
There is no suitable diagnostic and prognostic biomarker for gastric cancer. The biggest hurdles in biomarker discovery are (i) the low abundance of cancer cell-specific proteins that limits their detection...
8.
Toy W, Lim S, Loh M, Lim Y
Cell Signal
. 2009 Nov;
22(3):437-46.
PMID: 19887107
In our previous study, Endofin was validated to be a novel tyrosine phosphorylation target downstream of EGFR. Here, we attempted to map the signaling events associated with Endofin following activation...
9.
Lim S, Choong L, Kuan C, Yunhao C, Lim Y
J Proteome Res
. 2009 Jun;
8(8):4062-76.
PMID: 19530702
Genetic aberration of EGFR is one of the major molecular characteristics of breast cancer. However, the molecular changes associated with EGFR signaling during different stages of breast cancer development have...
10.
Ho J, Kong J, Choong L, Loh M, Toy W, Chong P, et al.
J Proteome Res
. 2008 Dec;
8(2):583-94.
PMID: 19086899
With the use of the breast cancer metastatic model, which comprises four isogenic cell lines, iTRAQ-based ESI-LC/MS/MS proteomics was employed to catalog protein expression changes as cancer cells acquire increasing...